Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 13Gastrointestinal 9Gynecologic 8Thoracic 4Lymphoid 3Dermatologic 3Other 2Endocrine 2Other hematologic neoplasm 1Head & Neck 1Genitourinary 1CNS 1

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 57Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Behavior × Endocrine × Clear all
NCT03781453 2020-04-08

POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

University of British Columbia

Phase NA Completed
498 enrolled
Endocrine

Behavior, Health Behavior, Multiple Endocrine Neoplasia Type 1

NCT03548077 2019-10-08

POWERPLAY

University of British Columbia

Phase NA Completed
227 enrolled
Endocrine

Behavior, Neoplasms, Health Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡